Enterprise Trust & Investment’s Boston Scientific BSX Stock Holding History

Enterprise Trust & Investment’s Portfolio BSX Stock Details BSX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	$2K	Buy	+67	New	+$2.73K	﹤0.01%	334

Other funds holding BSX

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Bollard Group Boston, Massachusetts $3.39B AUM 1.06% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Enterprise Trust & Investment's BSX Position: Q2 2022 in Review

Enterprise Trust & Investment opened a new position in Boston Scientific (BSX) in Q2 2022: 67 shares worth $2K. The stake represents ﹤0.01% of the portfolio and ranks #334 among its holdings.

878 funds tracked by Wall St. Rank hold BSX as of Q2 2022.

Enterprise Trust & Investment held 67 shares of Boston Scientific worth $2K as of Q2 2022.
Boston Scientific was a new Enterprise Trust & Investment position in Q2 2022.
Boston Scientific made up ﹤0.01% of Enterprise Trust & Investment's portfolio in Q2 2022, its #334 holding.
878 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2022.

Based on Enterprise Trust & Investment's 13F filing for Q2 2022, filed 22 Jul 2022.